Bender Robert & Associates’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-63,636
Closed -$3.84M 49
2016
Q2
$3.84M Buy
63,636
+8,351
+15% +$474K 2.71% 14
2016
Q1
$2.54M Sell
55,285
-215
-0.4% -$7.8K 1.72% 22
2015
Q4
$2.68M Sell
55,500
-130
-0.2% -$5.61K 1.72% 23
2015
Q3
$2.36M Sell
55,630
-54
-0.1% -$2.67K 1.6% 20
2015
Q2
$3.18M Buy
55,684
+1,516
+3% +$93.5K 1.89% 21
2015
Q1
$3.5M Buy
54,168
+1,002
+2% +$57.4K 2.04% 18
2014
Q4
$2.65M Buy
53,166
+210
+0.4% +$10.9K 1.73% 22
2014
Q3
$2.62M Sell
52,956
-312
-0.6% -$13.3K 1.82% 21
2014
Q2
$2.05M Buy
53,268
+2,460
+5% +$82.9K 1.45% 24
2014
Q1
$1.64K Buy
+50,808
New +$1.87M 1.1% 24

Other funds holding MDVN

Bender Robert & Associates's MDVN Position: Q3 2016 in Review

Bender Robert & Associates sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 63,636 shares — an estimated $3.84M sold.

Bender Robert & Associates first reported a position in MDVN in Q1 2014 and held it in 10 quarters. The position peaked at $3.84M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Bender Robert & Associates reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Bender Robert & Associates sold 63,636 MEDIVATION, INC. shares in Q3 2016, an estimated $3.84M.
  • Bender Robert & Associates first reported a position in MEDIVATION, INC. in Q1 2014 and held it in 10 quarters.
  • Bender Robert & Associates's MEDIVATION, INC. position peaked at $3.84M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Bender Robert & Associates's 13F filing for Q3 2016, filed 28 Oct 2016.